Literature DB >> 8821544

Electrophysiological effects of monoamine oxidase inhibition on rat midbrain dopaminergic neurones: an in vitro study.

N B Mercuri1, A Bonci, A Siniscalchi, A Stefani, P Calabresi, G Bernardi.   

Abstract

1 The effects of the inhibition of monoamine oxidase (MAO) type A and B have been evaluated on the spontaneous firing activity of the dopaminergic (principal) neurones of the rat midbrain intracellularly recorded from a slice preparation. 2 The non-specific MAO inhibitor, pargyline, superfused at a concentration of 10-100 microM, decreased or abolished the spontaneous firing discharge of the principal neurons in the subtantia nigra pars compacta and ventral tegmental area. This effect had a slow onset and appeared to be sustained. 3 The administration of the dopamine D2/3 receptor antagonist, sulpiride (100-300 nM), antagonized the pargyline-induced effect, while the superfusion of the dopamine D1 receptor antagonist, SCH 23390 (1-3 microM) did not counteract the induced inhibition of the firing rate. 4 The inhibitor for the MAO A, clorgyline (30-100 microM), reduced the firing rate of the dopaminergic neurones. A similar depressant effect was also observed when a MAO B inhibitor, deprenyl (30-100 microM), was applied. Lower concentrations of both drugs (300 nM-10 microM) did not produce consistent effects on neuronal discharge. 5 Our data suggest that only the blockade of both types of MAO enzymes favours the inhibitory action of endogenous dopamine on somato-dendritic D2/3 autoreceptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8821544      PMCID: PMC1909293          DOI: 10.1111/j.1476-5381.1996.tb15222.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.

Authors:  A R Green; B D Mitchell; A F Tordoff; M B Youdim
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

2.  Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity.

Authors:  J W Commissiong
Journal:  Biochem Pharmacol       Date:  1985-04-15       Impact factor: 5.858

3.  Effects of intrastriatal kainic acid injection on [3H]dopamine metabolism in rat striatal slices: evidence for postsynaptic glial cell metabolism by both the type A and B forms of monoamine oxidase.

Authors:  D D Schoepp; A J Azzaro
Journal:  J Neurochem       Date:  1983-05       Impact factor: 5.372

4.  Electrophysiology of pars compacta cells in the in vitro substantia nigra--a possible mechanism for dendritic release.

Authors:  R Llinás; S A Greenfield; H Jahnsen
Journal:  Brain Res       Date:  1984-02-27       Impact factor: 3.252

5.  Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.

Authors:  L G Hársing; E S Vizi
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

6.  The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.

Authors:  K T Demarest; D J Smith; A J Azzaro
Journal:  J Pharmacol Exp Ther       Date:  1980-11       Impact factor: 4.030

7.  Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites.

Authors:  A Imperato; G Di Chiara
Journal:  J Neurosci       Date:  1984-04       Impact factor: 6.167

8.  Distinct monoamine oxidase A and B populations in primate brain.

Authors:  K N Westlund; R M Denney; L M Kochersperger; R M Rose; C W Abell
Journal:  Science       Date:  1985-10-11       Impact factor: 47.728

9.  Cellular localization of MAO A and B in brain: evidence from kainic acid lesions in striatum.

Authors:  A Francis; L B Pearce; J A Roth
Journal:  Brain Res       Date:  1985-05-13       Impact factor: 3.252

10.  Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons.

Authors:  P Levitt; J E Pintar; X O Breakefield
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

View more
  2 in total

1.  Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.

Authors:  T Ilani; I Lamensdorf; J P Finberg
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

2.  Monoamine oxidase inhibition causes a long-term prolongation of the dopamine-induced responses in rat midbrain dopaminergic cells.

Authors:  N B Mercuri; M Scarponi; A Bonci; A Siniscalchi; G Bernardi
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.